LFVN Cash Flow Breakdown | LIFEVANTAGE CORP

LIFEVANTAGE CORP Cash Flow Breakdown

Cash flow breakdown shows where LIFEVANTAGE CORP's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2026-06-30: from running the business, $10.24M came in.
Fiscal year ended 2026-06-30: from investing, $7.31M went out.
Fiscal year ended 2026-06-30: from financing, $7.78M went out.
Fiscal year ended 2026-06-30: change in cash, $5.28M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Buybacks	Dividends	Debt paid back	New debt	Commercial paper	Staff share tax	New shares sold	Other	Not split out	Change in cash
2026-06-30	$10.24M	-$7.31M	-$2.04M	-$2.34M			$0.00*	-$3.62M				-$5.28M
2025-06-30	$11.88M	-$1.37M	-$3.15M	-$2.07M			$0.00*	-$2.66M				$3.31M
2024-06-30	$12.20M	-$2.25M	-$6.43M	-$6.94M				-$1.22M				-$4.72M
2023-06-30	$6.83M	-$3.06M	-$822.00K	-$1.59M				-$201.00K				$1.42M
2022-06-30	$7.96M	-$1.53M	-$8.83M	-$378.00K*	$0.00			-$246.00K				-$2.98M
2021-06-30	$16.27M	-$3.73M	-$11.93M	$0.00	$0.00			-$1.42M*				$1.04M
2020-06-30	$18.33M	-$2.68M	-$5.41M	$0.00	-$1.50M			-$6.25M			$729.00K*	$3.31M
2019-06-30	$17.79M	-$4.51M	-$4.66M		-$4.00M			-$3.17M			$701.00K*	$2.17M
2018-06-30	$13.26M	-$4.65M	-$1.50M		-$2.00M	$0.00		$0.00		$0.00		$5.19M
2017-06-30	$6.60M	-$1.05M	$0.00		-$2.00M	$0.00		$0.00		$0.00		$3.58M
2016-06-30	$6.04M	-$562.00K	$0.00		-$22.13M	$10.00M				$266.00K		-$6.02M
2015-06-30	$13.22M	-$1.16M	-$9.85M		-$9.20M	$0.00				$128.00K		-$6.48M
2014-06-30	$12.11M	-$2.25M	-$46.17M		-$16.18M	$45.83M				$655.00K		-$5.91M
2013-06-30	$10.66M	-$5.08M	-$7.12M		$0.00	$0.00			$1.69M	$1.41M		$1.65M
2012-06-30	$19.39M	-$1.90M	-$976.00K		$0.00	$0.00			$1.77M	$388.00K		$18.28M
2011-06-30	$4.68M	-$89.00K	$0.00						$169.00K	$0.00		$4.73M

Each quarter (3 month)

Quarter end	Running the business	From investing	Buybacks	Dividends	Debt paid back	New debt	Commercial paper	Staff share tax	New shares sold	Other	Not split out	Change in cash
2026-06-30	$4.77M*	-$1.04M*	-$460.00K*	-$625.00K*			$0.00*	-$65.00K*
2026-03-31	$4.99M*	-$1.01M*	-$1.01M*	-$573.00K*			$0.00*	-$103.00K*
2025-12-31	$2.79M*	-$4.83M*	$1.00K*	-$575.00K*				-$164.00K*
2025-09-30	-$2.31M	-$439.00K	-$578.00K	-$571.00K				-$3.28M				-$7.11M
2025-06-30	$1.03M*	-$199.00K*	-$2.03M*	-$562.00K*			$0.00*	-$648.00K*
2025-03-31	$2.23M*	-$331.00K*	$0.00	-$503.00K*			$0.00*	-$771.00K*
2024-12-31	$9.20M*	-$492.00K*	$0.00	-$502.00K*				-$898.00K*
2024-09-30	-$583.00K	-$345.00K	-$1.11M	-$500.00K				-$347.00K				-$2.29M
2024-06-30	$2.58M*	-$278.00K*	-$1.83M*	-$503.00K*				-$310.00K*
2024-03-31	$3.09M*	-$291.00K*	-$1.90M	-$448.00K*				-$233.00K*
2023-12-31	$1.76M*	-$543.00K*	-$1.90M	-$455.00K*				-$213.00K*
2023-09-30	$4.76M	-$1.13M	-$795.00K	-$5.53M				-$465.00K				-$3.20M
2023-06-30	$3.76M*	-$505.00K*	-$822.00K*	-$445.00K*				-$56.00K*
2023-03-31	$3.44M*	-$990.00K*	$0.00*	-$383.00K*				-$54.00K*	$0.00*
2022-12-31	$967.00K*	-$837.00K*	$0.00*	-$381.00K*				-$19.00K*	$0.00*
2022-09-30	-$1.34M	-$727.00K	$0.00	-$377.00K				-$72.00K	$0.00			-$2.57M
2022-06-30	$2.78M*	-$266.00K*	-$459.00K*	-$378.00K*				-$45.00K*
2022-03-31	$671.00K*	-$365.00K*	-$1.70M	$0.00*				-$31.00K*	$0.00*
2021-12-31	$4.04M*	-$521.00K*	-$3.20M	$0.00*				-$31.00K*	$0.00*
2021-09-30	$465.00K	-$378.00K	-$3.49M	$0.00				-$139.00K	$133.00K			-$3.25M
2021-06-30	$8.37M*	-$473.00K*	-$3.93M*		$0.00*			-$118.00K*
2021-03-31	$3.06M*	-$1.73M*	-$2.00M		$0.00*			-$126.00K*	$2.00K*
2020-12-31	$5.89M*	-$572.00K*	-$4.00M		$0.00*			-$666.00K*	$991.00K*
2020-09-30	-$1.05M	-$960.00K	-$2.00M		$0.00			-$506.00K	$11.00K			-$4.18M
2020-06-30	$9.35M*	-$574.00K*	$0.00*		$0.00*			-$150.00K*
2020-03-31	$3.21M*	-$474.00K*	-$2.00M*		-$500.00K*			-$1.68M*	$9.00K*
2019-12-31	$9.22M*	-$881.00K*	-$2.01M*		-$500.00K*			-$4.36M*	$54.00K*
2019-09-30	-$3.46M	-$752.00K	-$1.39M		-$500.00K			-$61.00K	$11.00K			-$5.82M
2019-06-30	$6.98M*	-$817.00K*	-$2.95M*		-$500.00K*			$0.00*
2019-03-31	$3.86M*	-$1.42M*	-$206.00K*		-$2.50M*			-$3.17M*	$381.00K*
2018-12-31	$4.58M*	-$786.00K*	-$1.50M*		-$500.00K*			$0.00*	$12.00K*			$1.87M*
2018-09-30	$2.37M	-$1.49M	$0.00		-$500.00K			$0.00	$172.00K			$471.00K
2018-06-30	$5.47M*	-$1.28M*	-$1.00M*		-$500.00K*			$0.00*				$2.70M*
2018-03-31	$3.10M*	-$1.25M*	-$200.00K		-$500.00K*				$30.00K*			$1.16M*
2017-12-31	$2.18M*	-$941.00K*			-$500.00K*				$0.00*			$506.00K*
2017-09-30	$2.50M	-$1.18M			-$500.00K				$0.00			$830.00K
2017-06-30	$1.98M*	-$591.00K*	$0.00*		-$500.00K*	$0.00*				$1.38M*		$2.26M*
2017-03-31	-$479.00K*	-$227.00K*	$0.00*		-$500.00K*				$33.00K*	-$1.38M*		-$2.53M*
2016-12-31	$2.22M*	-$143.00K*			-$500.00K*				$2.00K*	$0.00*		$1.51M*
2016-09-30	$2.88M	-$94.00K			-$500.00K				$5.00K	$0.00		$2.34M
2016-06-30	-$162.00K*	-$63.00K*	$0.00*		-$500.00K*	$0.00*				-$95.00K*		-$611.00K*
2016-03-31	-$2.31M*	-$166.00K*	$0.00*		-$14.81M*				$24.00K*	-$44.00K*	$9.90M*	-$7.33M*
2015-12-31	$5.67M*	-$330.00K*	$0.00*		-$3.70M*				$84.00K*	$424.00K*		$2.13M*
2015-09-30	$2.84M	-$3.00K	$0.00		-$3.12M				$0.00	-$19.00K		-$219.00K
2015-06-30	$4.26M*	-$56.00K*	$0.00*		-$5.67M*	$0.00*				-$20.00K*		-$1.45M*
2015-03-31	$995.00K*	-$240.00K*	-$3.24M*		-$1.18M*	$0.00*			$232.00K*	$148.00K*		-$3.29M*
2014-12-31	$2.90M*	-$627.00K*	-$4.61M*		-$1.18M*				$161.00K*	$0.00*		-$3.49M*
2014-09-30	$5.06M	-$236.00K	-$2.00M		-$1.18M				$35.00K	$0.00		$1.75M
2014-06-30	$1.93M*	-$577.00K*	-$3.00M*		-$15.00M*	$0.00*				$655.00K*		-$15.29M*
2014-03-31	$3.26M*	-$1.01M*	$0.00*		-$1.18M*	$0.00*			$87.00K*			$1.23M*
2013-12-31	$2.06M*	-$364.00K*	-$40.30M*		$0.00*				$899.00K*		$44.31M*	$6.50M*
2013-09-30	$4.85M	-$295.00K	-$2.87M		$0.00				$253.00K			$1.66M
2013-06-30	$595.00K*	-$455.00K*	-$2.23M*		$0.00*	$0.00*			-$372.00K*		$1.41M*	-$940.00K*
2013-03-31	$3.71M*	-$755.00K*	-$4.66M*						$565.00K*			-$1.23M*
2012-12-31	$5.45M*	-$2.30M*	-$238.00K*						$314.00K*			$3.29M*
2012-09-30	$915.00K	-$1.57M	$0.00						$1.19M			$530.00K
2012-06-30	$7.72M*	-$453.00K*	$0.00*									$7.75M*
2012-03-31	$3.62M*	-$744.00K*	-$325.00K*								$962.00K*	$3.44M*
2011-12-31	$4.71M*	-$330.00K*										$4.02M*
2011-09-30	$3.34M	-$369.00K										$3.07M
2011-06-30	$2.24M*	-$75.05K*										$2.28M*
2011-03-31	$1.33M*	-$7.61K*										$1.36M*
2010-12-31	$470.65K*	$1.60K*										$479.11K*
2010-09-30	$641.65K	-$7.94K										$619.38K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Adicet Bio, Inc. (ACET)	United States	$0.078B	-0.81
Valion Bio, Inc. (VBIO)	United States	$0.077B
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41